about
Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On TrialsThe Interface between Neuroscience and Neuro-Psychoanalysis: Focus on Brain ConnectivityAdverse Psychiatric Effects Associated with Herbal Weight-Loss Products25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drugSexual enhancement products for sale online: raising awareness of the psychoactive effects of yohimbine, maca, horny goat weed, and Ginkgo bilobaPharmacological treatments in gambling disorder: a qualitative review.Novel psychoactive substances in young adults with and without psychiatric comorbidities.New drugs on the Internet: the case of Camfetamine.Substance use in the club scene of Rome: a pilot study.The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview.Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products.Captagon: use and trade in the Middle East.A Case of Resistant Schizophrenia Successfully Treated With Clozapine/Long-acting Injectable Aripiprazole Combination.Novel psychoactive substances: use and knowledge among adolescents and young adults in urban and rural areas.Cannabis: a self-medication drug for weight management? The never ending story.Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza.A matter of life and death: substance-caused and substance-related fatalities in Ibiza in 2015.Bupropion as an add-on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence.Life (and death) in Pink: The dangerous rise of synthetic opioids in the new psychoactive substances panorama.The new drugs and the sea: The phenomenon of narco-terrorism.Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives.Shedding light on the "Blackout": risky behaviors and accidental deaths among adolescentsAugmenting pharmacotherapy with neuromodulation techniques for the treatment of bipolar disorder: a focus on the effects of mood stabilizers on cortical excitability
P50
Q26741541-663AEA41-6AF8-4572-AD4B-1C0A11A61D5AQ26766496-BC26BF2A-A89B-4C19-9DE1-03B334FE1D9FQ26784276-6D90B642-E5FC-4707-A8A1-28550E81F76DQ26822943-CF2CEE8C-34F1-4B08-9FD0-0D5AE5F929F5Q26859053-780A4CA7-921A-4AC2-B50B-507D100B5439Q33735862-07A66370-CD99-4382-8EE3-B7005812EB91Q34009299-EEDFD28D-1F92-42BF-A21D-D855A8C88D57Q34012349-246AC8DD-7DD1-4530-8572-3B5976733C9EQ34177273-297030A7-11B4-40AB-9FCD-21D2716CAA92Q38115597-600620D0-9840-4684-B01B-1C3EF3E7C23DQ38555624-7E721CBF-D077-4CF5-8A10-A95871B3CA40Q39263869-90C31536-4CB4-4321-A1A0-2C6638B91A3AQ39266859-77583038-BB29-4060-99E2-66EE01B444FBQ40300263-7FF6BA32-74F7-429A-A908-B16BBD4A7F78Q40443401-2178C71A-B75F-459A-9C2F-6C46196BAE9EQ47726010-AB7ACCE9-CEA6-4069-9471-2B4D96FE46ADQ48211738-35D1DE73-2587-49CA-95D0-AE818461DFE8Q48369480-9FD46164-221C-4C52-B01F-7317C599CCFFQ49713884-52B9A839-06E4-493E-9889-284A21444542Q49943615-182BE69B-4641-4E41-96B3-314A9B35447CQ55080181-1BC62A1E-AF79-445F-ABA8-83081659B613Q57800467-C8061CF4-734A-49D8-A0EB-FD58410FE89FQ92439791-6008466B-A90D-4C85-9C0A-AA705203E564
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rita Santacroce
@ast
Rita Santacroce
@en
Rita Santacroce
@es
Rita Santacroce
@nl
Rita Santacroce
@sl
type
label
Rita Santacroce
@ast
Rita Santacroce
@en
Rita Santacroce
@es
Rita Santacroce
@nl
Rita Santacroce
@sl
prefLabel
Rita Santacroce
@ast
Rita Santacroce
@en
Rita Santacroce
@es
Rita Santacroce
@nl
Rita Santacroce
@sl
P106
P21
P31
P496
0000-0003-1377-9183